Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 19;11(10):2859.
doi: 10.3390/jcm11102859.

Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective

Affiliations
Review

Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective

Theresa Ackfeld et al. J Clin Med. .

Abstract

Blood transfusions have been the cornerstone of life support since the introduction of the ABO classification in the 20th century. The physiologic goal is to restore adequate tissue oxygenation when the demand exceeds the offer. Although it can be a life-saving therapy, blood transfusions can lead to serious adverse effects, and it is essential that physicians remain up to date with the current literature and are aware of the pathophysiology, initial management and risks of each type of transfusion reaction. We aim to provide a structured overview of the pathophysiology, clinical presentation, diagnostic approach and management of acute transfusion reactions based on the literature available in 2022. The numbers of blood transfusions, transfusion reactions and the reporting rate of transfusion reactions differ between countries in Europe. The most frequent transfusion reactions in 2020 were alloimmunizations, febrile non-hemolytic transfusion reactions and allergic transfusion reactions. Transfusion-related acute lung injury, transfusion-associated circulatory overload and septic transfusion reactions were less frequent. Furthermore, the COVID-19 pandemic has challenged the healthcare system with decreasing blood donations and blood supplies, as well as rising concerns within the medical community but also in patients about blood safety and transfusion reactions in COVID-19 patients. The best way to prevent transfusion reactions is to avoid unnecessary blood transfusions and maintain a transfusion-restrictive strategy. Any symptom occurring within 24 h of a blood transfusion should be considered a transfusion reaction and referred to the hemovigilance reporting system. The initial management of blood transfusion reactions requires early identification, immediate interruption of the transfusion, early consultation of the hematologic and ICU departments and fluid resuscitation.

Keywords: adverse transfusion reactions; anemia treatment; blood cell transfusion; erythrocyte transfusion; pulmonary complications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of the most common acute transfusion reactions with treatment propositions. CBC = complete blood count; DIC = disseminated intravascular coagulation; BNP = brain natriuretic peptide; AHTR = acute hemolytic transfusion reaction; FNHTR = febrile non-hemolytic transfusion reaction; TRALI = transfusion-related acute lung injury; TACO = transfusion-associated circulatory overload; LDH = lactate dehydrogenase; ARDS = acute respiratory distress syndrome; LAH = left atrial hypertension; RBC = red blood cell.
Figure 2
Figure 2
Massive transfusion protocol algorithm. TASH score = Trauma Associated Severe Hemorrhage; RBC = red blood cell; pRBC = packed red blood cell; PCC = prothrombin complex concentrate (PCC); PT = prothrombin time; aPTT = activated partial thromboplastin time; MTP = massive transfusion protocol.

References

    1. Swissmedic Analyse des Annonces D’hémovigilance. 2020. [(accessed on 31 January 2022)]. Available online: https://www.swissmedic.ch/swissmedic/fr/home/humanarzneimittel/marktuebe....
    1. Swissmedic 2019 © Copyright The Swiss Haemovigilance Reporting System—Fundamentals. Swissmedic-Analyse des Annonces D’hémovigilance. 2018. [(accessed on 2 May 2022)]. Available online: https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktuebe....
    1. Swissmedic 2019 © Copyright The Swiss Haemovigilance Reporting System—Fundamentals. Swissmedic-Analyse des Annonces D’hémovigilance. 2017. [(accessed on 2 May 2022)]. Available online: https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktuebe....
    1. L’Agence Nationale de Sécurité du Médicament et des Produits de Santé-18eme Rapport National D’hémovigilance Dec, 2021. [(accessed on 23 March 2022)]. Available online: https://ansm.sante.fr/uploads/2021/12/08/20211208-rapport-hemovigilance-....
    1. Funk M.B., Heiden M., Muller S. Hämovigilanz-Bericht des Paul-Ehrlich-Instituts 2020: Auswertung der Meldungen von Reaktionen und Zwischenfällen nach § 63i AMG. 2021. [(accessed on 26 March 2022)]. Available online: www.pei.de/haemovigilanzbericht.

LinkOut - more resources